Schwarz, Anke
Schmitt, Roland
Einecke, Gunilla
Keller, Frieder
Bode, Ulrike
Haller, Hermann
Guenter, Hans Heinrich
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 13 July 2021
Accepted: 4 January 2022
First Online: 12 January 2022
Declarations
:
: The study protocol was approved by the Ethics Committee of Hannover Medical School, Chairman Prof. Dr. H. D. Troeger, Hannover, December 12, 2015 (IRB No. 2995–2015), one year before start of the study in 2017. Written informed consent of the patients to participate in the study was obtained. Since this was a retrospective observational case series and written consent of the patients was obtained for publication, according to the ethics’ board the analysis was exempt from IRB approval. Principles as outlined in the “Declaration of Helsinki” and the “Declaration of Istanbul on Organ Trafficking and Transplant Tourism” were respected.
: In the written informed of the patients consent for participation in the study, a written consent for publication of the anonymous results of the study was included.
: The authors of this manuscript have conflicts of interest to disclose: H.H. has received Lecture fees and Consultancy from Bayer, Vifor Pharma, Fresenius, Boehringer, Alexia, AstraZeneca, Sciarc AG; Board Member fees from Bayer, Vifor Pharma, Fresenius, Boehringer, Alexion, AstraZeneca; Research Grants from Vifor Pharma, Boehringer, AstraZeneca; No Travel Grants. The other authors declare that they have no financial or non-financial competing interests.